Supratentorial primitive neuroectodermal tumor in an adult: A case report and review of the literature

被引：6
作者：
Lawandy S. [1 ,2 ]
Hariri O.R. [1 ,2 ]
Miulli D.E. [1 ,2 ]
Amin J. [2 ]
Minasian T. [1 ,2 ]
Gupta R.K. [3 ]
Siddiqi J. [1 ,2 ]
机构：
[1] Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, CA 92324
[2] Department of Surgery, College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91766
[3] Department of Radiology, Harbor-UCLA Medical Center, Torrance, CA 90509
来源：
Journal of Medical Case Reports | / 6卷 / 1期
关键词：
TP53 Mutation; Primitive Neuroectodermal Tumor; Blurry Vision; Small Cell Neuroendocrine Carcinoma; Genetic Assay;
D O I：
10.1186/1752-1947-6-361
中图分类号：
学科分类号：
摘要：
Introduction. Supratentorial primitive neuroectodermal tumors predominantly occur in children, and are rare in the adult population. Less than 100 cases of supratentorial primitive neuroectodermal tumor have been reported in adults internationally. Our case study reports this rare incident. Case presentation. A 22-year-old Hispanic man presented with headaches, blurry vision, diplopia, intermittent vomiting, and grossly decreased vision. A magnetic resonance image showed a left posterior parietal heterogeneously enhancing mass measuring 4.2cm × 7.2cm × 7.0cm. After craniotomy for resection and decompression, the mass was histologically revealed to be a supratentorial primitive neuroectodermal tumor. Standardized immunohistochemical studies for this mass were carried out. Conclusion: We have concluded that immunohistochemical and genetic workup should be included in the standardized pathological workup for primitive neuroectodermal tumors in order to provide more prognostic information. Based on our current literature review, we propose an immunohistochemical panel. © 2012 Lawandy et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 12 条
  • [1] Ohba S., Yoshida K., Hirose Y., Ikeda E., Kawase T., A supratentorial primitive neuroectodermal tumor in an adult: A case report and review of the literature, Journal of Neuro-Oncology, 86, 2, pp. 217-224, (2008)
  • [2] Pizer B.L., Weston C.L., Robinson K.J., Ellison D.W., Ironside J., Saran F., Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study, Eur J Cancer, 42, 8, pp. 1120-1128, (2006)
  • [3] Gessi M., Setty P., Bisceglia M., Zur Muehlen A., Lauriola L., Waha A., Supratentorial primitive neuroectodermal tumors of the central nervous system in adults: Molecular and histopathologic analysis of 12 cases, Am J Surg Pathol, 35, 4, pp. 573-582, (2011)
  • [4] Pickuth D., Leutloff U., Computed tomography and magnetic resonance imaging findings in primitive neuroectodermal tumours in adults, British Journal of Radiology, 69, 817, pp. 1-5, (1996)
  • [5] Pigott T.J.D., Punt J.A.G., Lowe J.S., Henderson M.J., Beck A., Gray T., The clinical, radiological and histopathological features of cerebral primitive neuroectodermal tumours, British Journal of Neurosurgery, 4, 4, pp. 287-297, (1990)
  • [6] Shingu T., Kagawa T., Kimura Y., Takada D., Moritake K., Hoshii Y., Supratentorial primitive neuroectodermal tumor in an aged patient - Case report, Neurologia Medico-Chirurgica, 45, 10, pp. 530-535, (2005)
  • [7] Gyure K.A., Prayson R.A., Estes M.L., Extracerebellar primitive neuroectodermal tumors: A clinicopathologic study with bcl-2 and CD99 immunohistochemistry, Ann Diagn Pathol, 3, 5, pp. 276-280, (1999)
  • [8] Hayden J.T., Fruhwald M.C., Hasselblatt M., Ellison D.W., Bailey S., Clifford S.C., Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children, Cell Cycle, 8, 11, pp. 1806-1807, (2009)
  • [9] Chan A.W., Tarbell N.J., Black P.M., Louis D.N., Frosch M.P., Ancukiewicz M., Adult medulloblastoma: Prognostic factors and patterns of relapse, Neurosurgery, 47, 3, pp. 623-631, (2000)
  • [10] Frost P.J., Laperriere N.J., Wong C.S., Milosevic M.F., Simpson W.J., Pintilie M., Medulloblastoma in adults, Int J Radiat Oncol Biol Phys, 32, 4, pp. 951-957, (1995)
12